Page last updated: 2024-09-03

nifekalant hydrochloride and Adverse Drug Event

nifekalant hydrochloride has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, K1

Reviews

1 review(s) available for nifekalant hydrochloride and Adverse Drug Event

ArticleYear
[Preclinical evaluation of drug induced QT prolongation].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 121, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Cation Transport Proteins; Drug Design; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyrimidinones; Torsades de Pointes

2003